George Vratsanos

Statistics

Publications

Citations

976

H-Index

Active since

2001

Affiliations

Bristol-Myers Squibb (United States)(Current)

University of Leeds

Bristol-Myers Squibb (Sweden)

Universitair Ziekenhuis Leuven

Bristol-Myers Squibb (Germany)

George Vratsanos is an author at Bristol-Myers Squibb (United States) specializing in immunology, autoimmunity, and rheumatoid arthritis pharmacotherapy.

Publications per year

2001–2009

Publications

Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)

P. Emery, Patrick Durez, M Dougados et al. · Annals of the Rheumatic Diseases · 2009 · 257 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Abatacept inhibits progression of structural damage in rheumatoid arthritis: results from the long-term extension of the AIM trial

H K Genant, Charles Peterfy, René Westhovens et al. · Annals of the Rheumatic Diseases · 2007 · 157 citations · Full text

Medicine, Pharmacotherapy, Musculoskeletal Medicine +14

Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study

Maya H Buch, D L Boyle, Sanna Rosengren et al. · Annals of the Rheumatic Diseases · 2008 · 151 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Cd4+ T Cells from Lupus-Prone Mice Are Hyperresponsive to T Cell Receptor Engagement with Low and High Affinity Peptide Antigens

George Vratsanos, Sung Soo Jung, Yeong‐Min Park et al. · The Journal of Experimental Medicine · 2001 · 108 citations · Full text

Life Sciences, Immunology, Pathology +17

Reduction of inflammatory biomarker response by abatacept in treatment of rheumatoid arthritis.

Michael H. Weisman, Patrick Durez, David S. Hallegua et al. · PubMed · 2006 · 100 citations

Medicine, Immunology, Pharmacology +17

1–5 of 9